487 related articles for article (PubMed ID: 27549869)
1. Pyoderma gangrenosum: A clinico-epidemiological study.
Riyaz N; Mary V; Sasidharanpillai S; Roshin RA; Snigdha O; Latheef EN; Rahima S; Bindu V; Anupama RN; Sureshan DN; Sherjeena PV
Indian J Dermatol Venereol Leprol; 2017; 83(1):33-39. PubMed ID: 27549869
[TBL] [Abstract][Full Text] [Related]
2. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
3. [Pyoderma gangrenosum: a report of 15 cases and review of the literature].
Suárez-Pérez JA; Herrera-Acosta E; López-Navarro N; Vilchez-Márquez F; Prieto JD; Bosch RJ; Herrera E
Actas Dermosifiliogr; 2012 Mar; 103(2):120-6. PubMed ID: 21782147
[TBL] [Abstract][Full Text] [Related]
4. Clinical management of pyoderma gangrenosum.
Wollina U
Am J Clin Dermatol; 2002; 3(3):149-58. PubMed ID: 11978136
[TBL] [Abstract][Full Text] [Related]
5. Neutrophilic dermatoses: a review of current treatment options.
Cohen PR
Am J Clin Dermatol; 2009; 10(5):301-12. PubMed ID: 19658442
[TBL] [Abstract][Full Text] [Related]
6. Clinical features, causes, treatments, and outcomes of peristomal pyoderma gangrenosum (PPG) in 44 patients: The Mayo Clinic experience, 1996 through 2013.
Barbosa NS; Tolkachjov SN; El-Azhary RA; Davis MD; Camilleri MJ; McEvoy MT; Bridges AG; Wetter DA
J Am Acad Dermatol; 2016 Nov; 75(5):931-939. PubMed ID: 27473454
[TBL] [Abstract][Full Text] [Related]
7. Inpatient management of pyoderma gangrenosum: treatments, outcomes, and clinical implications.
Cabalag MS; Wasiak J; Lim SW; Raiola FB
Ann Plast Surg; 2015 Mar; 74(3):354-60. PubMed ID: 23903083
[TBL] [Abstract][Full Text] [Related]
8. Pyoderma gangrenosum--a review.
Wollina U
Orphanet J Rare Dis; 2007 Apr; 2():19. PubMed ID: 17433111
[TBL] [Abstract][Full Text] [Related]
9. Pyoderma gangrenosum demographics, treatments, and outcomes: an analysis of 2,273 cases.
Sasor SE; Soleimani T; Chu MW; Cook JA; Nicksic PJ; Tholpady SS
J Wound Care; 2018 Jan; 27(Sup1):S4-S8. PubMed ID: 29334018
[TBL] [Abstract][Full Text] [Related]
10. Pyoderma gangrenosum: a review with special emphasis on Latin America literature.
Rodríguez-Zúñiga MJM; Heath MS; Gontijo JRV; Ortega-Loayza AG
An Bras Dermatol; 2019; 94(6):729-743. PubMed ID: 31789268
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological features and prognosis of pyoderma gangrenosum in Korea: A single centre, retrospective, observational study over 20 years.
Kim YJ; Lee KH; Won CH; Chang SE; Lee MW; Choi JH; Lee WJ
Indian J Dermatol Venereol Leprol; 2023; 89(1):25-34. PubMed ID: 35389018
[TBL] [Abstract][Full Text] [Related]
12. Recurrent pyoderma gangrenosum after cesarean delivery successfully treated with vacuum-assisted closure and split thickness skin graft: a case report.
Aydın S; Aydın ÇA; Uğurlucan FG; Yaşa C; Dural Ö
J Obstet Gynaecol Res; 2015 Apr; 41(4):635-9. PubMed ID: 25370183
[TBL] [Abstract][Full Text] [Related]
13. Pyoderma gangrenosum of the hand: a case series and review of the literature.
Huish SB; de La Paz EM; Ellis PR; Stern PJ
J Hand Surg Am; 2001 Jul; 26(4):679-85. PubMed ID: 11466644
[TBL] [Abstract][Full Text] [Related]
14. Surgical treatment of pyoderma gangrenosum with negative pressure wound therapy and split thickness skin grafting under adequate immunosuppression is a valuable treatment option: Case series of 15 patients.
Pichler M; Larcher L; Holzer M; Exler G; Thuile T; Gatscher B; Tappeiner L; Deluca J; Carriere C; Nguyen VA; Moosbrugger-Martinz V; Schmuth M; Klein GF; Eisendle K
J Am Acad Dermatol; 2016 Apr; 74(4):760-5. PubMed ID: 26979359
[No Abstract] [Full Text] [Related]
15. [Pyoderma gangrenosum--clinical, laboratory and therapeutic approaches. Review of 28 cases].
Duarte AF; Nogueira A; Lisboa C; Azevedo F
Dermatol Online J; 2009 Jul; 15(7):3. PubMed ID: 19903431
[TBL] [Abstract][Full Text] [Related]
16. Accelerated healing of pyoderma gangrenosum treated with bioengineered skin and concomitant immunosuppression.
de Imus G; Golomb C; Wilkel C; Tsoukas M; Nowak M; Falanga V
J Am Acad Dermatol; 2001 Jan; 44(1):61-6. PubMed ID: 11148478
[TBL] [Abstract][Full Text] [Related]
17. [Pyoderma gangrenosum: a report of 3 cases].
Ma ZL; Zhang TL
Zhonghua Wai Ke Za Zhi; 2007 Nov; 45(21):1479-81. PubMed ID: 18275714
[TBL] [Abstract][Full Text] [Related]
18. Postoperative pyoderma gangrenosum (PG): the Mayo Clinic experience of 20 years from 1994 through 2014.
Tolkachjov SN; Fahy AS; Wetter DA; Brough KR; Bridges AG; Davis MD; El-Azhary RA; McEvoy MT; Camilleri MJ
J Am Acad Dermatol; 2015 Oct; 73(4):615-22. PubMed ID: 26209218
[TBL] [Abstract][Full Text] [Related]
19. The Association of Age With Clinical Presentation and Comorbidities of Pyoderma Gangrenosum.
Ashchyan HJ; Butler DC; Nelson CA; Noe MH; Tsiaras WG; Lockwood SJ; James WD; Micheletti RG; Rosenbach M; Mostaghimi A
JAMA Dermatol; 2018 Apr; 154(4):409-413. PubMed ID: 29450453
[TBL] [Abstract][Full Text] [Related]
20. [Extensive ulcerations in children: The difficulty diagnosing pyoderma gangrenosum].
Ramli I; Rachadi H; Amarouch H; Rimani M; Senouci K; Benzekri L; Hassam B
Arch Pediatr; 2015 Jul; 22(7):753-5. PubMed ID: 26047747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
